rts logo

Recursion Pharmaceuticals Inc (RXRX) Stock Could Soon Reward Patient Investors


Recursion Pharmaceuticals Inc (NASDAQ: RXRX) is -24.54% lower on its value in year-to-date trading and has touched a low of $4.97 and a high of $16.75 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RXRX stock was last observed hovering at around $7.40 in the last trading session, with the day’s gains setting it 0.04%.

Currently trading at $7.44, the stock is -12.48% and -14.81% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.32 million and changing 0.54% at the moment leaves the stock -16.27% off its SMA200. RXRX registered 8.45% gain for a year compared to 6-month loss of -37.64%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a -17.43% gain in the last 1 month and extending the period to 3 months gives it a -17.33%, and is -0.27% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.39% over the week and 6.19% over the month.

Profit margin for the company is -765.90%. Distance from 52-week low is 49.70% and -55.57% from its 52-week high. The company has generated returns on investments over the last 12 months (-79.40%).

The EPS is expected to shrink by -0.08% this year.

Recursion Pharmaceuticals Inc (RXRX) Top Institutional Holders

The shares outstanding are 226.26M, and float is at 192.35M with Short Float at 23.36%.

Recursion Pharmaceuticals Inc (RXRX) Insider Activity

The most recent transaction is an insider sale by Marriott Tina,the company’sPresident and COO. SEC filings show that Marriott Tina sold 6,000 shares of the company’s common stock on Jun 27 ’24 at a price of $7.21 per share for a total of $43290.0. Following the sale, the insider now owns 0.54 million shares.

Recursion Pharmaceuticals Inc disclosed in a document filed with the SEC on Jun 25 ’24 that Borgeson Blake (Director) sold a total of 11,447 shares of the company’s common stock. The trade occurred on Jun 25 ’24 and was made at $9.51 per share for $0.11 million. Following the transaction, the insider now directly holds 7.18 million shares of the RXRX stock.

Still, SEC filings show that on Jun 14 ’24, Secora Michael (Chief Financial Officer) disposed off 15,000 shares at an average price of $9.27 for $0.14 million. The insider now directly holds 1,267,843 shares of Recursion Pharmaceuticals Inc (RXRX).

Related Posts